JULIE SPENCER: Open Payments
NPI 1194719716 · BRAMBLETON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 23 payments from 9 companies in 2025. Trend: 2023 $969 · 2024 $485 · 2025 $838
Food & beverage: $738Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $266 |
| Sumitomo Pharma America, Inc. | 6 | $149 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $93 |
| Ferring Pharmaceuticals Inc. | 3 | $68 |
| Teleflex LLC | 2 | $59 |
| Procept Biorobotics Corporation | 1 | $51 |
| BIOPROTECT MEDICAL, INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: ERLEADA, GEMTESA, ZENPEP, ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, BARRIGEL, BIOPROTECT BALLOON IMPLANT SYSTEM, UROLIFT.
Industry payments across VA — which companies pay providers there.
